Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesCholinesterase Inhibitors and Incidence of Bradycardia in Patients with Dementia in the Veterans Affairs New England Healthcare System
Journal of the American Geriatrics Society, 10/13/09
Hernandez RK Et al. – Using a large cohort, a modestly greater risk of bradycardia was found in patients with dementia taking ChE–Is than in those not taking these drugs. In patients taking donepezil, the risk of bradycardia may increase with increasing doses. Because of the potential clinical consequences, monitoring for bradycardia may be warranted in patients with dementia treated with ChE–Is.
Related Articles
Cholinesterase Inhibitor Use in U.S. Nursing Homes: Results from the National Nursing Home Survey
Journal of the American Geriatrics Society, 10/29/09
Relevance Score: 80%
The existence of cognitive plateaus in Alzheimer's disease
Alzheimer's & Dementia, 11/13/09
Relevance Score: 78%
Variability in the Prescription of Cholinesterase Inhibitors and Memantine
Dementia and Geriatric Cognitive Disorders, 11/03/09
Relevance Score: 78%
Benefit Of Memantine In The Treatment Of Alzheimers Disease Not Proven
ScienceDaily, 10/29/09
Relevance Score: 78%
Review: statins do not protect against development of dementia
Evidence-Based Mental Health, 10/30/09
Relevance Score: 66%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Clopidogrel Hypersensitivity: A Novel Multi-Day Outpatient Oral Desensitization Regimen
Annals of Pharmacotherapy, 12/16/09
Reasonable Duration of Clopidogrel Use After Drug-Eluting Stent Implantation in Korean Patients
The American Journal of Cardiology, 12/16/09
Combination therapy of statins and fibrates in the management of cardiovascular risk
Current Opinion in Lipidology, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor